Test Price
2,800 AED✅ Home Collection Available
NLRP7 Gene Hydatidiform Mole Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Diagnostic Precision
99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited Next Generation Sequencing (NGS) performed in a DHA‑licensed facility (License No. 1143).
Premium Logistics
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM daily). Available across all UAE emirates.
Clinical Guidance
Post‑test telephonic clinical interpretation session with a consultant medical geneticist included. Discuss your NLRP7 results and actionable steps.
Insurance Verification
Fast Direct Billing check via WhatsApp: +971 54 548 8731
Test Overview & Methodology
The NLRP7 Gene Hydatidiform Mole Genetic Test detects pathogenic mutations in the NLRP7 gene that cause recurrent complete hydatidiform moles (familial molar pregnancies). This test uses high‑depth Next Generation Sequencing with full exon and flanking intron coverage, ensuring detection of single nucleotide variants, small insertions/deletions, and copy number variants. The analysis is performed in a DHA-licensed laboratory under stringent quality controls.
| Feature | Our NGS Test | Closest Alternative (Sanger Single‑Gene) |
|---|---|---|
| Methodology | NGS – Whole gene sequencing (SNVs, indels, CNVs) | Targeted Sanger sequencing of select exons |
| Sensitivity | >99.9% diagnostic sensitivity | ~95% if limited to common mutations |
| Turnaround Time | 3‑4 Weeks | 4‑6 Weeks |
| Clinical Report | DHA‑compliant, ICD‑10 coded, genetic counselling note included | Basic mutation list |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403): “The NLRP7 genetic test provides critical predisposition information for recurrent hydatidiform mole. However, results must be interpreted in the context of a comprehensive clinical workup including hCG trends and imaging. A negative result does not preclude all molar pregnancy risks. This test empowers informed reproductive choices and family screening. Always discuss findings with your treating gynecologist for a multidisciplinary approach.”
Medication & Clinical Advisory
Do not discontinue any prescribed medication, including fertility treatments or anticoagulants, without explicit instruction from your treating physician. Genetic test results should not be used to self‑adjust therapy. Always consult a qualified healthcare professional for clinical decisions.
Patient Safety: Exclusion Criteria & Emergency Red Flags
- Exclusion: This blood‑based test should be delayed if you have an active systemic infection, severe coagulopathy, or haematocrit <20%. For FTA card collection, ensure no contamination with other body fluids.
- Red Flag (ER): If you experience sudden severe pelvic pain, heavy vaginal bleeding, passage of grape‑like cysts, or symptoms of hyperthyroidism (tachycardia, tremor, heat intolerance), seek emergency gynaecologic evaluation immediately – these may indicate active molar pregnancy complications.
- Pre‑test Requirement: A genetic counselling session to draw a pedigree chart is mandatory before sample collection. This helps identify familial patterns and informs interpretation of variants of uncertain significance.
Patient FAQ & Clinical Guidance
1. How does the NLRP7 genetic test differ from routine molar pregnancy follow‑up?
This test directly sequences the NLRP7 gene to identify germline mutations that predispose to recurrent hydatidiform moles, enabling proactive reproductive planning and family‑wide risk assessment beyond standard monitoring.
2. What sample types are accepted and is home collection available?
Accepted samples: whole blood, extracted DNA, or a single drop of blood on an FTA card. Our VIP Mobile Phlebotomy service provides temperature-controlled home collection across all UAE emirates daily from 8 AM to 11 PM.
3. How will I receive my results and can a doctor explain them?
A secure, encrypted PDF report is available within 3‑4 weeks. A post‑test teleconsultation with a consultant medical geneticist is included to guide you through the findings, implications, and recommended follow‑up.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Security: This test complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genomic data is encrypted in transit and at rest, and access is restricted to authorized clinical personnel only.
Patient Safety & Consent: Informed consent is obtained prior to sample collection in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability. Pre‑test genetic counselling is mandatory to ensure full understanding of the implications.
Clinical & Logistical Metadata
| Test Name | NLRP7 Gene Hydatidiform Mole Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3‑4 Weeks |
| Sample Type / Matrix | Whole blood (EDTA), extracted DNA, or FTA card |
| Methodology Used | Next Generation Sequencing (NGS) – Full NLRP7 gene coverage |
| ICD-10-CM Code | O01.9, O01.0, O01.1 |
| LOINC Code | 93385-8 |
| DHA Facility License & Laboratory Address Invariants | DHA Facility License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians